MedPath

MRI examination of the breast in the context of BI-RADS 3 findings requiring control 6 months after initial pre-operative breast MRI

Not Applicable
Conditions
C50
Malignant neoplasm of breast
Registration Number
DRKS00030512
Lead Sponsor
niversitätsklinikum Tübingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting stopped after recruiting started
Sex
Female
Target Recruitment
5
Inclusion Criteria

Punch biopsy confirmed unifocal breast carcinoma,
- Age >50 years,
- Written informed consent of the patient.

Exclusion Criteria

- Multifocal or bilateral breast carcinoma,
- Hereditary breast carcinoma, such as BRCA1/2,
- Contrast agent allergy,
- Contraindication for MRI.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysis of the diagnostic value of mammary MRI 6 Monte after insertion of the paramagnetic particles for sentinel lymph node labeling, and assessability of the axilla.
Secondary Outcome Measures
NameTimeMethod
Opportunities to reduce susceptibility artifacts using specialized MRI sequences, such as WARP.
© Copyright 2025. All Rights Reserved by MedPath